Suven, Cohance announce merger
The merged platform to comprise three distinct business units – Pharma CDMO, Spec Chem CDMO, and API+ (inclusive of formulations)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Nezglyal remains promising therapy despite EMA’s market authorisation refusal: GlobalData
Nezglyal is a novel orally bioavailable and selective peroxisome proliferator-activated receptor (PPAR) gamma agonist that is…
FDA denial could delay launch of Minerva’s schizophrenia treatment roluperidone by at least two…
To address the clinical deficiencies stated in the CRL, Minerva must provide additional safety and efficacy data for roluperidone…
Zeno Health secures $25 million in Series C funding
Fund round was led by Korean PE investor STIC Investments and supported by existing investor Lightbox
FOPE request govt for funding to MSME to upgrade manufacturing facilities for revised Schedule M
The letter states that the said scheme may be similar to that which is for upgrading for WHO GMP
Orchid Pharma gets USFDA approval for Exblifep
Enmetazobactam is the first completely invented-in-India Beta Lactamase Inhibitor
FOPE writes to govt raising concerns about new Schedule M amendment
The new Schedule M states that manufacturing premises must be exclusively used for the production of drugs, barring any other…
VeerHealth Care plans expansion, to invest Rs 33 crores
This investment encompasses various aspects including the acquisition of land, construction of buildings, procurement of plant and…
Takeda oncology pipeline remains robust despite shift in focus from CAR-T to allogeneic cell…
Takeda entered into multiple cell therapy collaborations for the development of CAR-T therapies with organizations like Memorial…
Daiichi Sankyo poised to add another ADC blockbuster with datopotamab deruxtecan for non-squamous…
GlobalData estimates the drug to earn $3.12 billion by 2029
India pharma giants and global big pharma join forces for NMEs commercialisation in India:…
The focus is on introducing new molecular entities (NMEs) into India, with both parties contributing to accelerate…
Top 20 global biopharma companies report 1.6 per cent per cent market cap growth to $3.67 tn in…
Four companies – Lilly (59.2 per cent), Novo Nordisk (51.5 per cent), Vertex Pharmaceuticals (41.4 per cent) and Regeneron…
Alkaloid has developed ready-to-use liquid Omeprazole
This drug is primarily designed to treat reflux esophagitis and GERD in young children unable to swallow tablets, as well as in…
Alirocumab can address unmet needs in pediatric familial hypercholesterolemia: GlobalData
Praluent (alirocumab) is a monoclonal antibody against proprotein convertase subtilisin kexin type 9 (PCSK9), an enzyme that…
Iovance’s AMTAGVI (lifileucel) gets US FDA accelerated approval for advanced melanoma
AMTAGVI is the first FDA-approved T cell therapy for a solid tumor cancer and first treatment option for advanced melanoma after…
Colorectal cancer market across 8MM to reach $21.8 bn in 2031: GlobalData
This uptrend is primarily driven by rising diagnosis rates, notably in key markets like the US and China and approvals of 13…
AstraZeneca’s DKD pipeline highlights potential to differentiate in kidney disease space: GlobalData
Unmet needs in the kidney disease space include next-generation therapies with alternate mechanisms of action and enhanced…
Aparna Group forays into pharma gets USFDA clearance for pharma manufacturing unit
Aparna Pharmaceuticals announced that its manufacturing facility, Aparna Organics, located in Pydibhimavaram, Srikakulalam, Andhra…
Fredun Pharma gets orders from SEA Countries
Also expands product development in veterinary care, and advances orthopaedic applications
Deal value increased by 19.2 per cent in Jan 2024, compared to Jan 2023: GlobalData
VC investments increased by 11.2 per cent in Jan 2024, compared to Jan 2023